Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study Conducted in the Emergency Department

Habibe Selmin Ozensoy; Serhat Örün; Selahattin Gürü; Esra Fırat Oguz

doi:10.12659/MSM.947703

20 March 2025 : Clinical Research

Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study Conducted in the Emergency Department

Habibe Selmin Ozensoy

^{ABCDEF 1*}, Serhat Örün

^{ACDEFG 2}, Selahattin Gürü

^{ABDEF 1}, Esra Fırat Oguz

^{ABDF 3}

DOI: 10.12659/MSM.947703

Med Sci Monit 2025; 31:e947703

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Descriptive characteristics of IS patient and control groups comparing Nardilysin and neurogranin values and their comparison with each other.

	Ng Group (n)	Control Group (n)	P value
Sex
Female	23	21	=0.83
Male	21	23	=0.83
Age	71.48±14.19	66.52±8.93	=0.1
BMI	26.25±4.35	24.11±2.12
IS – ischemic stroke; BMI – body mass index.

Back to the Article

Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study Conducted in the Emergency Department

Your Privacy